Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Sepsis

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    March 2021
  1. RIOS A
    Kaposi sarcoma: a fresh look.
    AIDS. 2021;35:515-516.
    PubMed    


    September 2020
  2. CHRISTOPOULOS KA, Neilands TB, Dilworth S, Lisha N, et al
    Internalized HIV stigma predicts subsequent viremia in US HIV patients through depressive symptoms and antiretroviral therapy adherence.
    AIDS. 2020;34:1665-1671.
    PubMed     Abstract available


    August 2020
  3. INZAULE SC, Bertagnolio S, Kityo CM, Siwale M, et al
    The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa.
    AIDS. 2020;34:1559-1566.
    PubMed     Abstract available


  4. LESKO CR, Chander G, Moore RD, Lau B, et al
    Variation in estimated viral suppression associated with the definition of viral suppression used.
    AIDS. 2020;34:1519-1526.
    PubMed     Abstract available


    February 2020
  5. MCCAUSLAND MR, Lebron AC, Pilch-Cooper HA, Howell S, et al
    Toll-like receptor distribution in colonic epithelium and lamina propria is disrupted in HIV viremic, immune success and failure.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002499.
    PubMed     Abstract available


    September 2019
  6. NELSON JAE, de Paris K, Ramirez C, Edmonds A, et al
    Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002373.
    PubMed     Abstract available


    August 2019
  7. REQUENA S, Caballero E, Lozano AB, Rios-Villegas MJ, et al
    Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002338.
    PubMed     Abstract available


    July 2019
  8. FLEMING J, Mathews WC, Rutstein RM, Aberg J, et al
    Low level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002306.
    PubMed     Abstract available


  9. DELL'ACQUA R, Galli L, Poli A, Mastrangelo A, et al
    Viro-immunological outcomes after thirteen-valent pneumococcal vaccination in HIV-1 infected subjects on stable virological suppression.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002307.
    PubMed     Abstract available


    May 2019
  10. PAIM AC, Cummins NW, Natesampillai S, Garcia-Rivera E, et al
    HIV elite control is associated with reduced TRAILshort expression.
    AIDS. 2019 May 29. doi: 10.1097/QAD.0000000000002279.
    PubMed     Abstract available


    March 2019
  11. PILCHER CD, Porco TC, Facente SN, Grebe E, et al
    A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results.
    AIDS. 2019 Mar 11. doi: 10.1097/QAD.0000000000002190.
    PubMed     Abstract available


    January 2019
  12. COOK RR, Fulcher JA, Tobin NH, Li F, et al
    Effects of HIV viremia on the gastrointestinal microbiome of young men who have sex with men.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002132.
    PubMed     Abstract available


    November 2018
  13. DE AZEVEDO SSD, Delatorre E, Cortes FH, Hoagland B, et al
    HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection.
    AIDS. 2018 Nov 27. doi: 10.1097/QAD.0000000000002090.
    PubMed     Abstract available


  14. WANG R, Haberlen SA, Palella FJ Jr, Mugavero MJ, et al
    Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough?
    AIDS. 2018;32:2547-2556.
    PubMed     Abstract available


    August 2018
  15. KANTOR R, Delong A, Schreier L, Reitsma M, et al
    HIV Second-Line Failure and Drug Resistance at High- and Low-Level Viremia in Western Kenya.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001964.
    PubMed     Abstract available


    April 2018
  16. BULL ME, Mitchell C, Soria J, Styrchak S, et al
    Monotypic low-level HIV viremias during ART are associated with disproportionate production of X4 virions and systemic immune activation.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001824.
    PubMed     Abstract available


    June 2017
  17. GARCIA-KNIGHT MA, Nduati E, Hassan AS, Nkumama I, et al
    Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants.
    AIDS. 2017 Jun 12. doi: 10.1097/QAD.0000000000001568.
    PubMed     Abstract available


    March 2017
  18. WINCKELMANN A, Barton K, Hiener B, Schlub TE, et al
    Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations.
    AIDS. 2017;31:771-779.
    PubMed     Abstract available


  19. YANG OO, Cumberland WG, Escobar R, Liao D, et al
    Demographics and natural history of HIV-1-infected spontaneous controllers of viremia: extremes on a continuum.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001443.
    PubMed     Abstract available


    November 2016
  20. CHRISTOPOULOS K, Hartogensis W, Glidden DV, Pilcher CD, et al
    The lorenz curve: a novel method for understanding viral load distribution at the population level.
    AIDS. 2016.
    PubMed     Abstract available


    January 2016
  21. CALIN R, Hamimi C, Lambert-Niclot S, Carcelain G, et al
    Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir.
    AIDS. 2016.
    PubMed     Abstract available


    July 2015
  22. GUIHOT A, Dentone C, Assoumou L, Parizot C, et al
    Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia.
    AIDS. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sepsis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: